3 / 10Cochin Shipyard | Udupi Cochin Shipyard Ltd., a wholly-owned subsidiary has signed a contract with Wilson ASA, Norway for the design and construction of four 6,300 TDW Dry Cargo Vessels.
An Agreement has also been signed for four additional vessels of the same kind, which will be formally contracted by September 19 this year.
The overall cost of the eight vessels is said to be ₹1,100 crore and Cochin Shipyard plans to execute this order by September 2028.
4 / 10Godrej Properties | Acquires leasehold rights for 11 acre land parcel in Pune with a revenue potential of ₹1,800 crore.
The company has also acquired nearly 7 acre of land in Bengaluru with an estimated revenue potential of nearly ₹1,200 crore.
1 / 10
Auto Stocks | To report sales figures for the month of June on Monday.
2 / 10
Vodafone Idea | Increases tariffs for its pre-paid and post-paid customers from July 4, 2024. Tariffs hiked across pre-paid and post-paid plans by 10% to 21%. To invest in enhancing 4G experience and launch 5G services over the next few quarters.
3 / 10
Cochin Shipyard | Udupi Cochin Shipyard Ltd., a wholly-owned subsidiary has signed a contract with Wilson ASA, Norway for the design and construction of four 6,300 TDW Dry Cargo Vessels. An Agreement has also been signed for four additional vessels of the same kind, which will be formally contracted by September 19 this year. The overall cost of the eight vessels is said to be ₹1,100 crore and Cochin Shipyard plans to execute this order by September 2028.
4 / 10
Godrej Properties | Acquires leasehold rights for 11 acre land parcel in Pune with a revenue potential of ₹1,800 crore. The development on this land will comprise of Group housing and high street retail. The company has also acquired nearly 7 acre of land in Bengaluru with an estimated revenue potential of nearly ₹1,200 crore.
5 / 10
Zydus Life | Announces licensing agreement with Dr. Reddy's Laboratories for co-marketing of Pertzumab Biosimilar, a critical treatment for breast cancer patients in India. The product will be marketed by Zydus under the brand name "Sigrima", while DRL will market it under the brand name "Womab." Zydus will receive upfront licensing income and is eligible to receive milestone income based on achievement of pre-defined milestones.
6 / 10
Orchid Pharma | Partners with Cipla to launch antibiotic Cefepime-Enmetazobactam in India. The drug has been approved for the treatment of complicated Urinary Tract Infections, Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia Indications. The partnership with Cipla is to ensure widespread and rapid distribution of this antibiotic combination across India.
7 / 10
UltraTech Cement | Commissions an additional 3.35 MTPA Clinker and 1.8 MTPA grinding capacity at its existing unit at Tadipatri in Andhra Pradesh.
8 / 10
Neogen Chemicals | Promoter divests nearly 5.7% ownership in the company via block deals. SBI Mutual Fund and White Oak Group were buyers in that transaction.
9 / 10
Bank of Baroda | To consider capital raising plan for financial year 2025 by raising funds on July 5. To raise funds via Additional Tier-1 and Tier-2 debt capital instruments with an interchangeability option.
10 / 10
